ProCE Banner Activity

New Insights on Oral and Long-Acting PrEP From CROI 2025: Perspectives From Africa

Clinical Thought

CROI 2025 highlighted innovative approaches to HIV pre-exposure prophylaxis (PrEP), including novel drugs, further analyses of landmark studies, and novel ways to leverage existing prevention methods. Read on to learn how these data could shape the PrEP landscape in Africa.

Released: April 10, 2025

Expiration: April 09, 2026

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

Disclosure

Primary Author

Kenneth Ngure, MPH, MSc, PhD, has no relevant financial relationships to disclose.